News
GNTA
1.490
+4.93%
0.070
Weekly Report: what happened at GNTA last week (1222-1226)?
Weekly Report · 12/29/2025 10:34
Maxim Group Sticks to Their Buy Rating for Genenta Science SpA Sponsored ADR (GNTA)
TipRanks · 12/23/2025 12:55
Weekly Report: what happened at GNTA last week (1215-1219)?
Weekly Report · 12/22/2025 10:34
Weekly Report: what happened at GNTA last week (1208-1212)?
Weekly Report · 12/15/2025 10:43
Market Pulse: Tilray Leads After-Hours Rally As Biotech Peers Surge
NASDAQ · 12/15/2025 02:51
Weekly Report: what happened at GNTA last week (1201-1205)?
Weekly Report · 12/08/2025 10:41
Weekly Report: what happened at GNTA last week (1124-1128)?
Weekly Report · 12/01/2025 10:36
Weekly Report: what happened at GNTA last week (1117-1121)?
Weekly Report · 11/24/2025 10:41
Genenta Science provides update from TEM-GBM study
TipRanks · 11/24/2025 10:10
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
Barchart · 11/24/2025 03:00
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11/20/2025 21:06
Earnings Momentum Lifts PACS And Nutex; Zynex And Genenta Also Advance After Hours
NASDAQ · 11/20/2025 04:43
Weekly Report: what happened at GNTA last week (1110-1114)?
Weekly Report · 11/17/2025 10:42
Weekly Report: what happened at GNTA last week (1103-1107)?
Weekly Report · 11/10/2025 10:39
Genenta Science Expands Board and Corporate Purpose Following Shareholders’ Meeting
TipRanks · 11/04/2025 11:33
Weekly Report: what happened at GNTA last week (1027-1031)?
Weekly Report · 11/03/2025 10:39
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 10/29/2025 17:06
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/29/2025 12:06
Why Teradyne Shares Are Trading Higher By More Than 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/29/2025 09:05
GNTA, BBIO, AMRN Jump After Hours: Key Biotech Catalysts Driving Stock Gains
NASDAQ · 10/29/2025 05:03
More
Webull provides a variety of real-time GNTA stock news. You can receive the latest news about Genenta Science Spa through multiple platforms. This information may help you make smarter investment decisions.
About GNTA
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.